Chiseliţă D, Drănişteanu D
Clinica Oftalmologică Iaşi.
Oftalmologia. 1995 Oct-Dec;39(4):322-32.
A new model of intermediate artificial drainage system (called microtrabeculoprosthesis--MTP) in the surgery of refractory glaucoma is suggested. The prospective study includes 37 operated cases followed up for an average interval of 18.2 months (ranges 11 and 72 months). Surgery is not difficult, and MTP is very well tolerated. A relief of elevated intraocular pressure (IOP < or = 20 mm Hg) was obtained in 73% of the cases (with or without additional antiglaucoma drugs); the irritative phenomena have disappeared in preterminal and absolute glaucoma; the overall therapeutic success rate was 86.5%. The results obtained with MTP are definitely superior to those by conventional surgery but inferior to modern posterior artificial drainage systems (with ameliorative techniques); the rate of postoperative complications is small, and their severity is minimal. In the absence of modern posterior artificial drainage systems. MTP is an efficient solution for the treatment of refractory glaucoma.
提出了一种用于难治性青光眼手术的新型中间人工引流系统模型(称为微小梁假体——MTP)。前瞻性研究纳入了37例手术病例,平均随访间隔为18.2个月(范围为11至72个月)。手术并不困难,且MTP耐受性良好。73%的病例眼压得到缓解(眼压≤20 mmHg,无论是否使用其他抗青光眼药物);在晚期和绝对期青光眼中,刺激症状消失;总体治疗成功率为86.5%。MTP所获得的结果明显优于传统手术,但不如现代后部人工引流系统(采用改良技术);术后并发症发生率低,严重程度也最小。在没有现代后部人工引流系统的情况下,MTP是治疗难治性青光眼的有效解决方案。